Comparison

TB-500 vs Pentadecapeptide

Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research

Preclinical

A synthetic 17-amino acid fragment of Thymosin Beta-4 (TB-4). Unlike TB-4, TB-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. Note: Many vendors mislabel TB-4 as 'TB-500' in premixed products.

HealingAnimal Studies
Pentadecapeptide

Also: BPC-157 Full Sequence, Stable Gastric Pentadecapeptide

Preclinical

The full 15-amino acid sequence that includes BPC-157. While BPC-157 is more commonly discussed, the full pentadecapeptide has similar healing properties derived from gastric juice.

HealingAnimal Studies

Key Comparison Insights

  • Both peptides belong to the Healing category, suggesting similar primary applications.

Detailed Comparison

AttributeTB-500Pentadecapeptide
CategoryHealingHealing
FDA StatusNot FDA ApprovedNot FDA Approved
Clinical Status
Pre
I
II
III
IV
FDA
Pre
I
II
III
IV
FDA
Mechanism of ActionTB-500 is derived from the active region of the full Thymosin Beta-4 protein. It promotes cell migration by binding to and sequestering actin, a protein essential for cell movement. It upregulates actin expression, promotes angiogenesis, reduces inflammation, and facilitates hair follicle stem cell migration for wound healing.Like BPC-157, the pentadecapeptide modulates the nitric oxide system, promotes angiogenesis, and accelerates tissue healing. It interacts with multiple growth factor systems and has cytoprotective effects on various tissues.
Common Dosing
2-2.5 mg twice weekly (loading), then 2.5 mg once weekly (maintenance)
2x weekly for 4-6 weeks, then 1x weekly
Limited community data available
See research protocols
AdministrationSubcutaneous or intramuscular injectionSubcutaneous injection
Typical Duration4-6 weeks loading, then maintenance4-12 weeks typical
Best Time to TakeMorning or eveningMorning and evening (or near injury site timing)
Possible Side Effects
May vary by individual
  • Generally well-tolerated
  • Injection site reactions
  • Headache
  • Fatigue
  • Nausea
  • +4 more
  • See BPC-157 (same compound)
  • Generally well-tolerated
  • Nausea
  • Dizziness
  • May trigger histamine release - use caution with MCAS or histamine sensitivity
Research SummaryAnimal studies show significant wound healing acceleration, cardiac tissue repair after heart attack, and anti-inflammatory effects. Preclinical research demonstrates improved recovery from dermal wounds and muscle injuries. No human clinical trials have been conducted. FDA has restricted TB-500 from compounding under Category 2 regulations.Research largely overlaps with BPC-157 studies, showing tissue healing, gastroprotection, and recovery enhancement. The pentadecapeptide terminology is sometimes used interchangeably with BPC-157 in scientific literature.

Frequently Asked Questions: TB-500 vs Pentadecapeptide

What is the difference between TB-500 and Pentadecapeptide?

TB-500 is a healing peptide that a synthetic 17-amino acid fragment of thymosin beta-4 (tb-4). unlike tb-4, tb-500 has a longer half-life (~2-4 days vs ~2 hours) and is the active region responsible for tissue repair and cell migration. note: many vendors mislabel tb-4 as 'tb-500' in premixed products. Pentadecapeptide is a healing peptide that the full 15-amino acid sequence that includes bpc-157. while bpc-157 is more commonly discussed, the full pentadecapeptide has similar healing properties derived from gastric juice. The main differences lie in their mechanisms of action and clinical applications.

Which is better, TB-500 or Pentadecapeptide?

Neither is universally "better" - the choice depends on your specific goals. TB-500 is typically used for healing purposes, while Pentadecapeptide is used for healing. Always consult with a healthcare provider to determine which may be appropriate for your situation.

Can TB-500 and Pentadecapeptide be used together?

Some peptide protocols combine multiple compounds for synergistic effects. However, using TB-500 and Pentadecapeptide together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.

Related Comparisons

View Full Peptide Profiles

Educational Information Only

This comparison of TB-500 and Pentadecapeptide is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.